To create an account the user’s real name and email address must be supplied.
The account can be set to receive notifications or not. Notifications are emails sent out when events like randomisation or unblinding occurs. Administrators receive notifications for all such events in the trial. Accounts that are limited to a particular site only receive notifications related to that site. Notification only accounts can also be created. Once the account is created an automatically generated email is sent to the email address supplied containing the randomly generated password necessary to access the account. An example of the generated email is:
From: email@example.com Subject: Confidential: new account details Date: 15 July 2015 11:10:17 BDT To: firstname.lastname@example.org Dear Joe Bloggs, An account with administrator privileges has been created for you to access JUMP. You can access the system online at https://www.sealedenvelope.com/access using these details: Email: email@example.com Temporary password: 2TVuxGR7 After you have logged in you will be required to change your password. If you have any difficulties please contact Simon Admin (firstname.lastname@example.org). Note, this message was auto-generated on Tue 15 Jul 2014 11:10 Europe/London (GMT +0100) and was sent from an email address that does not accept replies. _____________________________________ Sealed Envelope http://www.sealedenvelope.com
Sometimes a user may already have an account on the system for a different trial. Attempting to create a new account for an existing email address will trigger an error. A link will be shown to allow the existing account to be associated with the new trial. The user will receive an email informing them that their existing account has been associated with the new trial.
If your trial is making use of Sealed Envelope’s telephone randomisation service, you can give access to this service by specifying an investigator number when creating the account. The investigator number must be a unique 3 digit number in the range 100-999.
When the user calls the telephone randomisation service they must enter the study number and investigator number to gain access to the system. These are shown to administrators and users with telephone access on the trials summary page.